Grace Therapeutics, Inc. (GRCE) stock
GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
$1.81−0.04 (-2.43%)
Close on Nov 12, 2026Market cap $38.08MP/E –Yield –
Grace Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Grace Therapeutics's profit margin for the twelve months ending Mar 31, 2022 was -9.8%. For fiscal 2022 it was -9.8%, against -10039.8% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Mar 31, 2022 | -9.8% | +10030.0 |
| FY2021 | Mar 31, 2021 | -10039.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -3.9% | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -4909.6% | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -3975.3% | – |
See a number that looks wrong?